What is the CVR number of BIO-MEDICAL CONSULT ApS?

BIO-MEDICAL CONSULT ApS is registered with CVR / Virk under CVR 25166701.

What is the revenue of BIO-MEDICAL CONSULT ApS?

BIO-MEDICAL CONSULT ApS reported revenue of DKK 155K in 2016.

Who is the CEO of BIO-MEDICAL CONSULT ApS?

Dennis Gilbert Møller is Audit of BIO-MEDICAL CONSULT ApS, in role since 2000.

Where is BIO-MEDICAL CONSULT ApS headquartered?

BIO-MEDICAL CONSULT ApS's registered address is M.A. Schultz Vej 7.

BIO-MEDICAL CONSULT ApS

APSDissolved

CVR 25166701M.A. Schultz Vej 7Virksomhedsrådgivning og anden rådgivning om driftsledelse · NACE 702200Est. 2000— employees

Full Risika report

Revenue 2016

DKK 155K

+43% vs 2015

EBITDA margin

100.0%

+43% vs 2015

Equity ratio

75.9%

Financial strength

Net profit 2016

DKK 253K

+69% vs 2015

EBITDA — year on yearDKK millions

Key figuresAnnual report 2016

Revenue	DKK 155K	+43%
EBITDA	DKK 155K	+43%
Net profit	DKK 253K	+69%
Total assets	DKK 12,2M	+13%
Equity	DKK 9,3M	+9%
Employees	—	—

Item	2012	2013	2014	2015	2016
Revenue	1.166	1.277	2.460	109	155
Staff expenses	-0	-0	-0	-0	-0
EBITDA	1.166	1.277	2.460	109	155
Depreciation & amort.	-0	-0	-30	-30	-33
EBIT	1.166	1.277	2.430	79	122
Net financials	212	39	249	120	203
Profit before tax	1.378	1.315	2.679	199	325
Tax	353	332	662	49	72
Net profit	1.025	984	2.018	150	253

Item	2012	2013	2014	2015	2016
Total assets	7.438	8.102	12.258	10.831	12.203
Equity	6.759	7.743	9.788	8.462	9.256
Long-term debt	0	204	0	0	0
Short-term debt	678	145	2.450	2.346	2.772
Total debt	678	349	2.450	2.346	2.772

Name	Role	Member since
Former (2)
DG Dennis Gilbert Møller Audit	Audit	2000 – 2015
LA Lars Arendt-Nielsen Management	Management	2000 – 2017

Shareholder	Type	Ownership	Votes	Since
BIO-MEDICAL CONSULT HOLDING ApS	Company	100%	100%	2009

Person	Role here	Other companies
Dennis Gilbert Møller	Audit	0 companies
Lars Arendt-Nielsen	Management	0 companies

BIO-MEDICAL CONSULT ApS

APSDissolved

CVR 25166701M.A. Schultz Vej 7Virksomhedsrådgivning og anden rådgivning om driftsledelse · NACE 702200Est. 2000— employees

Full Risika report

Revenue 2016

DKK 155K

+43% vs 2015

EBITDA margin

100.0%

+43% vs 2015

Equity ratio

75.9%

Financial strength

Net profit 2016

DKK 253K

+69% vs 2015

EBITDA — year on yearDKK millions

Key figuresAnnual report 2016

Revenue	DKK 155K	+43%
EBITDA	DKK 155K	+43%
Net profit	DKK 253K	+69%
Total assets	DKK 12,2M	+13%
Equity	DKK 9,3M	+9%
Employees	—	—